CXCL13 and colorectal carcinoma: Furthermore, the increased expression of B-lymphocyte chemoattractant (BLC) reported here is consistent with earlier studies on its role in CRC pathogenesis, since deficiency and the blockade of BLC signaling attenuates disease progression [33].